Primary XXXX : a single centre experience.

@entity1 @entity632 @entity706 @entity229 @entity786 @entity1891 @entity1893
AIM: Primary @entity706 (PTL) is an uncommon and aggressive form of extranodal @entity1893 ( @entity1893 ). We aimed to analyse the clinicopathological characteristics and outcomes of our PTL cases. MATERIALS AND METHODS: A review was made of the medical records of 339 @entity1893 @entity1 who were treated in the Medical Oncology Department between January 2005 and December 2013. RESULTS: 8 PTL @entity1 were identified from the 339 @entity1893 @entity1 . The average age of the @entity1 was 67.7    7.9 years (range 53-79 years). The mean follow-up time was 24.8 months (range 7-98 months). Inguinal orchiectomy was performed as a diagnostic and initial therapy and all the @entity1 underwent 4-6 cycles of chemoimmunotherapy consisting of @entity786 , @entity632 , @entity1891 and @entity229 plus rituximab. 4 of 8 @entity1 received intrathecal prophylactic chemotherapy and 6 of 8 @entity1 continued contralateral testis irradiation. Relapse occured in only 1 @entity1 in central nervous system after 6 months who had not received intrathecal prophylaxis. No contralateral testis relapse was observed. CONCLUSIONS: Primary @entity1893 is an uncommon entity and we evaluated 8 @entity1 ; with one relapse in central nervous system and no relapse in the contralateral testis.
